Skip to main content
AstraZeneca PLC logo

AstraZeneca PLC — Investor Relations & Filings

Ticker · AZN ISIN · GB0009895292 LEI · PY6ZZQWO2IZFZC3IOL08 IL Manufacturing
Open in API
Filings indexed 3,403 across all filing types
Latest filing 2019-03-14 Proxy Solicitation & In…
Country GB United Kingdom
Listing IL AZN

About AstraZeneca PLC

https://www.astrazeneca.com/

AstraZeneca PLC is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. The company's portfolio is concentrated on several main therapy areas, including Oncology; Cardiovascular, Renal & Metabolism; and Respiratory & Immunology. AstraZeneca is committed to advancing healthcare through a robust research and development pipeline, aiming to deliver innovative medicines that address significant unmet medical needs for millions of patients worldwide. The company leverages scientific innovation to transform the future of healthcare and improve patient outcomes.

Recent filings

Filing Released Lang Actions
Proxy Form
Proxy Solicitation & Information Statement Classification · 100% confidence The document is an 'Attendance Card' and 'Proxy Form' for AstraZeneca's 2019 Annual General Meeting. It includes instructions for shareholders on how to vote, appoint a proxy, and attend the meeting. These materials are sent to shareholders to solicit their votes for the upcoming AGM, which fits the definition of a Proxy Solicitation & Information Statement.
2019-03-14 English
Chairman's Letter
AGM Information Classification · 95% confidence The document is a letter addressed to shareholders from the Chairman of AstraZeneca PLC, dated March 14, 2019. The primary purpose of the letter is to announce that the 'Annual Report and Form 20-F Information 2018' and the 'Notice of Annual General Meeting 2019 and Shareholders' Circular' have been published. It also contains shareholder information regarding dividends, communication preferences, and warnings about scams. Since the document is an announcement *about* the publication of the Annual Report and the Notice of AGM, and it is relatively short (under 5,000 characters based on the provided snippet, although the total length is 13272 chars, the content structure strongly suggests an accompanying letter/notice rather than the full 10-K or AGM materials), it fits the definition of a Report Publication Announcement (RPA) or potentially a communication related to the AGM (AGM-R) or a general regulatory filing (RNS). However, the text explicitly mentions the publication of the 'Annual Report and Form 20-F Information 2018' and the 'Notice of Annual General Meeting 2019'. The presence of the Notice of AGM materials strongly suggests this communication is intrinsically linked to the AGM process. Given the dual nature (announcing the Annual Report AND the Notice of AGM), and the fact that it is a formal communication to shareholders regarding these events, 'AGM-R' (AGM Information) is a strong candidate, as the Notice of AGM is a key component. If it were purely announcing the 10-K, 'RPA' would be better. Since it is a shareholder communication covering the AGM notice and dividend details, 'AGM-R' is the most specific fit among the options that cover shareholder meetings/notices. Revisiting the definitions: AGM-R is for 'Presentations and materials shared during the Annual General Meeting (AGM)'. This document is the *pre-meeting* communication (Notice of AGM). DEF 14A is for Remuneration. PSI is for Proxy Solicitation. Since the document explicitly mentions the 'Notice of Annual General Meeting 2019' and provides proxy card information, it is most closely related to the AGM process. Given the options, and the fact that it is a formal shareholder communication accompanying the AGM notice, AGM-R is selected over RPA because the AGM notice is a central theme.
2019-03-14 English
AGM Notice
AGM Information Classification · 99% confidence The document explicitly states 'Notice of AGM' and 'Notice of Annual General Meeting 2019 and Shareholders' Circular'. It details the agenda for the Annual General Meeting (AGM) scheduled for April 26, 2019, including resolutions regarding accounts, auditor reappointment, director elections, remuneration reports, and share allotment authorities. This content is characteristic of materials distributed to shareholders in preparation for an AGM, which falls under the 'AGM Information' category.
2019-03-14 English
DIRECTOR/PDMR SHAREHOLDING
Regulatory Filings
2019-03-12 English
Director/PDMR Shareholding
Remuneration Information Classification · 99% confidence The document begins with 'RNS Number' and is dated 12 March 2019. The content explicitly details 'TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES (PDMRs)' regarding the granting of share awards under company plans (AZDBP and AZPSP) to executives like Pascal Soriot and Marc Dunoyer. This type of insider transaction reporting, especially when disseminated via RNS (Regulatory News Service), directly corresponds to the definition of Director's Dealing (DIRS). Although it mentions the Annual Report for context on performance measures, the primary purpose and content are the director transactions.
2019-03-12 English
FILING OF FORM 20-F WITH SEC
Regulatory Filings
2019-03-06 English

Browse filings by year

34 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.